About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
13
As Collaborator
0
Total Enrollment
1,540
By Phase
PHASE1: 5PHASE2: 3PHASE2/PHASE3: 5
By Status
COMPLETED: 11RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT07015398Lead Sponsor
A Study of the Pharmacokinetic Interaction Between Pirfenidone, Nintedanib, and Nalbuphine Extended Release (NAL ER) in Healthy Participants
PHASE1Completed
132 participants
Started: Jun 30, 2025 · Completed: Sep 26, 2025
NCT07036029Lead Sponsor
NAL ER IPF Respiratory Function and Safety Study
PHASE1Recruiting
10 participants
Started: Jun 30, 2025 · Completed: Oct 31, 2025
NCT05964335Lead Sponsor
Cough Reduction in IPF With Nalbuphine ER
PHASE2Completed
165 participants
Started: Feb 6, 2024 · Completed: Apr 24, 2025
NCT05962151Lead Sponsor
Refractory Chronic Cough Improvement Via NAL ER (RIVER)
PHASE2Completed
66 participants
Started: Nov 30, 2023 · Completed: Jan 6, 2025
NCT04030026Lead Sponsor
A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough
PHASE2Completed
42 participants
Started: Oct 29, 2019 · Completed: May 27, 2022
Locations (1)
Headquarters
New Haven, CT, United States
Map
Loading map...